Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.
With an ageing population, an increasing number of chronic sick, a growing range of treatment options and a developing European market, the one certainty is that medication patterns will change radically in the future. How the future might look, in terms of quality, volume and cost of pharmacotherapy, is the subject of this report. Four scenarios for the future are set out, all of which take account of already visible trends. Sobriety in sufficiency envisages rational and restrained consumption patterns. Risk of avoidance is dominated by fears of iatrogenic harm and hence minimal drug use. Free market unfettered, finally, is marked by a Europe without frontiers and minimal state intervention. The reader is encouraged to reflect on the future of medicines in health care.
Summary. 1. Introduction. 2. Scenario analysis. 3. Determinants of drug innovation and utilization. 4. The place of medicines in the treatment of seven disease categories. 5. Driving forces. 6. Four scenarios for the future of medicines in health care. 7. In conclusion. References. Acknowledgements.
Scenario Committee on AIDS, E.J. Ruitenberg, F.M.L.G. van den Boom, J.C. de Jager, D.P. Reinkind, M.J. Postma, C.E.S. Albers, Scenario Committee on Aids, E. J. Ruitenberg, F. M. L. G. van den Boom, J. C. de Jager, D. P. Reinkind, M. J. Postma, C. E. S. Albers
Scenario Committee on AIDS, E.J. Ruitenberg, F.M.L.G. van den Boom, J.C. de Jager, D.P. Reinkind, M.J. Postma, C.E.S. Albers, Scenario Committee on Aids, E. J. Ruitenberg, F. M. L. G. van den Boom, J. C. de Jager, D. P. Reinkind, M. J. Postma, C. E. S. Albers